Macquarie University, Sydney Macquarie University ResearchOnline

Showing items 1 - 3 of 3.

Add to Quick Collection   All 3 Results

  • First
  • Previous
  • 1
  • Next
  • Last
Sort:
 Add All Items to Quick Collection
Date: 2016
Language: eng
Resource Type: journal article
Identifier: http://hdl.handle.net/1959.14/1183579
Description: The anti-PD-1 antibodies nivolumab and pembrolizumab are active in metastatic melanoma; however, there is limited data on combining anti-PD-1 antibody and radiotherapy (RT). We sought to review clinic ... More
Reviewed: Reviewed
Date: 2015
Language: eng
Resource Type: conference paper abstract
Identifier: http://hdl.handle.net/1959.14/1114219
Description: 1 page(s)
Date: 2015
Language: eng
Resource Type: conference paper abstract
Identifier: http://hdl.handle.net/1959.14/1116489
Description: Introduction: Immunotherapy with anti CTLA-4 (Ipilimumab) or anti PD-1 (Pembrolizumab, Nivolumab) antibodies are now the standard of care for metastatic melanoma and other malignancies. These drugs ha ... More
Reviewed: Reviewed
  • First
  • Previous
  • 1
  • Next
  • Last